|
Eduard E. Holdener, M.D., 63, was elected as Director of the Company in January 2008, coinciding with his retirement from F. Hoffmann-La Roche, Ltd. in Basel Switzerland, after 22 years of service. From January 1999 until his retirement, Dr. Holdener served as Head of Global Pharmaceutical Development and also served as the Company�s Chief Medical Officer. During his career with the Company, he helped to establish and expand the oncology therapeutic area, and led the Company�s development operations in Japan for several years in the late 90�s. Prior to joining Roche, Dr. Holdener held positions as a clinical oncologist in hospital settings and academic institutions, both in Switzerland and the United States. Dr. Holdener received his Medical Degree from the University of Zurich and Basel Medical School in Switzerland, and completed his fellowship in Oncology at the University of Kansas Medical Center in the United States. He is Board Certified in Internal Medicine and Oncology/Hematology in Switzerland.
| 